CSL has reached the upper end of its trading range. In line with our commitment to optimizing returns and managing risks effectively, we are taking profit on the remaining 2% of our CSL position.
Take Profit Telix Pharma (TLX) in our balanced portfolio, we will take half our allocation for a 15.8% profit as we see the overall market underperforming in the next couple of weeks.
A recent rally in the underlying Uranium price has seen the spot price rally from $80 to a fresh 16-year of $104. We have hit profit target for Deep Yellow and taken a 26% profit on the trade.
A recent rally in the underlying Uranium price. The we have hit the recent highs for Paladin and recommend taking our position off as it has hit profit target.
Sell 2.5% holding in Ventia services for 10% profit
A recent rally in the underlying Uranium price. The we have hit the recent highs for Paladin and recommend taking half our position off for a quick scalp.
